DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ...
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groups Accelerated rates ...
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...
Groups G and H used pure GLP-1 drugs (semaglutide and liraglutide respectively) in DehydraTECH compositions Recalculations led to slight changes from earlier reported data Lexaria is strongly ...
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...
Kelowna-based Lexaria Closes $5 Million Financing via Private Placement (Registered Direct Offering)
Bioscience Corp. (Nasdaq:LEXX; LEXXW), a developer of drug delivery platforms, today announced that it has closed a ...
Just because a business does not make any money, does not mean that the stock will go down. By way of example, Lexaria Bioscience (NASDAQ:LEXX) has seen its share price rise 199% over the last year, ...
Lexaria notes that it has already filed patent applications to recognize the unique outperformance of liraglutide once processed with DehydraTECH delivery technology. Readers are cautioned to not ...
KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it ...
KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has clo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback